Healthcare
Live Price
Offline$97.09
+0.00% today
Window Change
-61.16%
Window
Jun 23, 2025 → Apr 29, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 197 bars · Jun 23, 2025 → Apr 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BerGenBio ASA (BRRGF) is a Healthcare stock with a market cap of $9.49B. The stock last traded around $97.09 and down 61.2% across the available one-year price window (Jun 23, 2025 → Apr 29, 2026). Baseline metrics include revenue growth of +139.5%, EPS growth of +41.6%, a dividend yield of 0.0%. What stands out right now is revenue +139.5%, EPS +41.6%, free cash flow +31.9% with operating margin -2133.2% and ROIC -172.1%. Valuation already assumes a fairly strong business story at price/sales 39.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines BRRGF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BRRGF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BRRGF Max Drawdown
-99.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BRRGF and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.